MétaCan
Menu
Back to cohort
Record W2121134690 · doi:10.1093/jnci/dju015

RE: Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial

2014· letter· en· W2121134690 on OpenAlexaff
J. Thomas Brenna, Graham C. Burdge, Michael A. Crawford, Paul Clayton, Stephen C. Cunnane, Rachel V. Gow, Joseph R. Hibbeln, Andrew J. Sinclair, John Stein, Peter Willatts

Bibliographic record

VenueJNCI Journal of the National Cancer Institute · 2014
Typeletter
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicCancer, Lipids, and Metabolism
Canadian institutionsUniversité de Sherbrooke
Fundersnot available
KeywordsProstate cancerPhospholipidProstateMedicineCancerChemistryInternal medicineOncologyBiochemistry

Abstract

fetched live from OpenAlex

We would like to take this opportunity to comment on the recent article by Brasky et al. ( 1 ). This study is a case–control study, measuring only associations rather than cause and effect, and it uses inappropriate measures of dietary exposure to omega-3 fatty acids, which show very low consumption levels overall. The abstract concludes by stating, “This study confirms previous reports of increased prostate cancer risk among men with high blood concentrations of LCω-3PUFA. The consistency of these findings suggests that these fatty acids are involved in prostate tumorigenesis. Recommendations to increase LCω-3PUFA intake should consider its potential risks” ( 1 ). We would like to draw your readers’ attention to the following matters of biological relevance in this study. First, the research used plasma phospholipid (PL) fatty acids as a measure of long-term intake of different fatty acids, but the literature regards plasma PL only as a measure of recent fat intakes ( 2 ). However, for the sake of our argument, let’s assume that plasma PL long-chain omega-3 fatty acids from blood taken some years ago can be used to grade risk of a disease many years later. The Brasky et al. study ( 1 ) reported levels of long-chain omega-3s that are in a very narrow range as follows: the no cancer group had mean levels of 4.48%, the low-grade cancer group had mean values of 4.66%, and the high-grade cancer group had levels of 4.71%. By way of comparison, vegetarians who consume no long-chain omega-3 have plasma PL long-chain omega-3 levels of 4.1% ( 3 ), and subjects fed a fish-rich diet for 2 weeks had plasma PL levels of 21.5% ( 4 ). Thus, the authors’ conclusion that a difference of 0.23% in omega-3 levels between the no cancer group and the high-grade cancer group is one that represents a biologically meaningful difference in long-chain omega-3 dietary intakes is fanciful. The statistics may give a P value implying significance, but the actual difference is so small as to be biologically irrelevant. The literature shows that this very narrow range of values is within the measurement error for these fatty acids. In fact, the authors suggest that all subjects had similar low dietary intakes. Thus, we believe the conclusions drawn substantially overstate the biological relevance of the research. The authors could have referred to a number of meta-analyses published recently, which have reported that intake of fish is associated with a reduction in deaths from prostate cancer, see for example, Szymanski et al. ( 5 ).

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.030
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Commentary · Consensus signal: Commentary
Teacher disagreement score0.023
Threshold uncertainty score0.048

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.030
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.002
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0020.002
Open science0.0030.001
Research integrity0.0230.021
Insufficient payload (model declined to judge)0.0140.014

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.297
Teacher spread0.273 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreCommentary

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations18
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueJNCI Journal of the National Cancer InstituteSame topicCancer, Lipids, and MetabolismFrench-language works237,207